St. Jude proceeds with study of next-gen CRT defibrillator

05/3/2013 | MassDevice.com (Boston)

St. Jude Medical has begun patient enrollment in a U.S. study of its Quadra Assura MP system, a next-generation cardiac resynchronization therapy defibrillator for multipoint pacing. The trial, which will involve more than 500 participants, will test whether the device can be used in patients who may not benefit from or respond to traditional CRT single-point pacing.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA